Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0VQ3O
|
||||
| Former ID |
DNC013516
|
||||
| Drug Name |
1-(oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529284] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H15NO3
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)OC2=CC=C(C=C2)CCC(=O)C3=NC=CO3
|
||||
| InChI |
1S/C18H15NO3/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)22-15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2
|
||||
| InChIKey |
LLQSCQSWBWHWLL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529284] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.